Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiangdong Qiu

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Cellular Oncology (Dordrecht, Netherlands)|October 30, 2020
CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinomaGang Yang, Yicheng Wang, Jianchun Xiao, et al.
Cancer Medicine|September 3, 2019
Novel discoveries targeting gemcitabine-based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?Wenhao Luo, Gang Yang, Jiangdong Qiu, et al.
Surgery in Practice and Science|April 9, 2026
Surgical training program of parathyroidectomy for residents in a national center: a cohort of 122 casesQiaofei Liu, An Song, Shiji Cheng, et al.
Molecular Cancer Research : MCR|February 6, 2020
OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2Gang Yang, Guangbing Xiong, Mengyu Feng, et al.
Signal Transduction and Targeted Therapy|June 21, 2026
Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, open-label phase 2 studyZhe Cao, Jiangdong Qiu, Wenhao Luo, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 16, 2023
Epidemiology of pancreatic cancer: New version, new visionWenhao Luo, Jun Wang, Hao Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2021
Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft ModelsGang Yang, Wenfang Guan, Zhe Cao, et al.
Journal of Gastroenterology|August 28, 2021
A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after pancreaticoduodenectomyZhe Cao, Jiangdong Qiu, Junchao Guo, et al.
Oncogenesis|June 27, 2026
Integrated scRNA-Seq and functional profiling reveal CD52 as a driver of pancreatic ductal adenocarcinoma metastasis and immunosuppressionZeyu Zhang, Jinxin Tao, Yifan Fu, et al.
Cells|March 6, 2021
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer CellsYibo Fu, Francesca Ricciardiello, Gang Yang, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Cellular Oncology (Dordrecht, Netherlands)|October 30, 2020
CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinomaGang Yang, Yicheng Wang, Jianchun Xiao, et al.
Cancer Medicine|September 3, 2019
Novel discoveries targeting gemcitabine-based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?Wenhao Luo, Gang Yang, Jiangdong Qiu, et al.
Surgery in Practice and Science|April 9, 2026
Surgical training program of parathyroidectomy for residents in a national center: a cohort of 122 casesQiaofei Liu, An Song, Shiji Cheng, et al.
Molecular Cancer Research : MCR|February 6, 2020
OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2Gang Yang, Guangbing Xiong, Mengyu Feng, et al.
Signal Transduction and Targeted Therapy|June 21, 2026
Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, open-label phase 2 studyZhe Cao, Jiangdong Qiu, Wenhao Luo, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 16, 2023
Epidemiology of pancreatic cancer: New version, new visionWenhao Luo, Jun Wang, Hao Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2021
Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft ModelsGang Yang, Wenfang Guan, Zhe Cao, et al.
Journal of Gastroenterology|August 28, 2021
A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after pancreaticoduodenectomyZhe Cao, Jiangdong Qiu, Junchao Guo, et al.
Oncogenesis|June 27, 2026
Integrated scRNA-Seq and functional profiling reveal CD52 as a driver of pancreatic ductal adenocarcinoma metastasis and immunosuppressionZeyu Zhang, Jinxin Tao, Yifan Fu, et al.
Cells|March 6, 2021
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer CellsYibo Fu, Francesca Ricciardiello, Gang Yang, et al.
Pageof 6